What is the door-to-needle time goal for 85% or more of acute ischemic stroke patients treated with IV thrombolytics?

The goal for door-to-needle time for acute ischemic stroke patients treated with intravenous (IV) thrombolytics is set at 60 minutes or less for 85% or more of patients. This target is critical because timely administration of thrombolytics can significantly improve outcomes for stroke patients. Rapid initiation of treatment increases the chances of minimizing brain damage, thus enhancing recovery and function for those affected by an ischemic stroke.

This emphasis on the 60-minute timeline stems from evidence-based guidelines that aim to optimize the management of stroke patients and promote best practices in acute care settings. Ensuring that a high percentage of patients receive treatment within this timeframe is essential for effective stroke treatment protocols and reflects the goals of continuous quality improvement in healthcare settings.